| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.780 | - | - | - | - | 3.895 | 3.809 | - | - | - |
| Total Income - EUR | 3.782 | - | - | - | - | 3.895 | 3.809 | - | - | - |
| Total Expenses - EUR | 2.953 | - | - | - | - | 2.012 | 2.014 | - | - | - |
| Gross Profit/Loss - EUR | 828 | - | - | - | - | 1.884 | 1.794 | - | - | - |
| Net Profit/Loss - EUR | 753 | - | - | - | - | 1.766 | 1.683 | - | - | - |
| Employees | 0 | - | - | - | - | 0 | 0 | - | - | - |
Check the financial reports for the company - Marank Special Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.537 | - | - | - | - | 4.364 | 4.102 | - | - | - |
| Current Assets | 12.055 | - | - | - | - | 14.363 | 16.270 | - | - | - |
| Inventories | 0 | - | - | - | - | 0 | 0 | - | - | - |
| Receivables | 142 | - | - | - | - | 124 | 121 | - | - | - |
| Cash | 11.912 | - | - | - | - | 14.238 | 16.148 | - | - | - |
| Shareholders Funds | 12.087 | - | - | - | - | 17.993 | 19.277 | - | - | - |
| Social Capital | 45 | - | - | - | - | 41 | 40 | - | - | - |
| Debts | 7.505 | - | - | - | - | 734 | 1.095 | - | - | - |
| Income in Advance | 0 | - | - | - | - | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Marank Special Bio Srl